Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

Watchlist Manager
Laboratorios Farmaceuticos ROVI SA Logo
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Watchlist
Price: 54 EUR 2.37% Market Closed
Market Cap: 2.8B EUR

Intrinsic Value

The intrinsic value of one ROVI stock under the Base Case scenario is 68.27 EUR. Compared to the current market price of 54 EUR, Laboratorios Farmaceuticos ROVI SA is Undervalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ROVI Intrinsic Value
68.27 EUR
Undervaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Laboratorios Farmaceuticos ROVI SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ROVI
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ROVI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
ES
Pharmaceuticals
Market Cap
2.8B EUR
IPO
Oct 26, 2007
ES
Pharmaceuticals
Market Cap
2.8B EUR
IPO
Oct 26, 2007
Price
false
EPS
false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Laboratorios Farmaceuticos ROVI SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Laboratorios Farmaceuticos ROVI SA

Current Assets 489.6m
Cash & Short-Term Investments 27.4m
Receivables 129.6m
Other Current Assets 332.6m
Non-Current Assets 342.4m
Long-Term Investments 19.5m
PP&E 286.6m
Intangibles 34m
Other Non-Current Assets 2.3m
Efficiency

Free Cash Flow Analysis
Laboratorios Farmaceuticos ROVI SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Laboratorios Farmaceuticos ROVI SA

Revenue
763.7m EUR
Cost of Revenue
-285.4m EUR
Gross Profit
478.3m EUR
Operating Expenses
-298.8m EUR
Operating Income
179.5m EUR
Other Expenses
-42.7m EUR
Net Income
136.9m EUR
Fundamental Scores

ROVI Profitability Score
Profitability Due Diligence

Laboratorios Farmaceuticos ROVI SA's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
69/100
Profitability
Score

Laboratorios Farmaceuticos ROVI SA's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

ROVI Solvency Score
Solvency Due Diligence

Laboratorios Farmaceuticos ROVI SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
85/100
Solvency
Score

Laboratorios Farmaceuticos ROVI SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ROVI Price Targets Summary
Laboratorios Farmaceuticos ROVI SA

Wall Street analysts forecast ROVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ROVI is 79.79 EUR with a low forecast of 65.55 EUR and a high forecast of 96.6 EUR.

Lowest
Price Target
65.55 EUR
21% Upside
Average
Price Target
79.79 EUR
48% Upside
Highest
Price Target
96.6 EUR
79% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
May 12, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for ROVI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ROVI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ROVI stock?

The intrinsic value of one ROVI stock under the Base Case scenario is 68.27 EUR.

Is ROVI stock undervalued or overvalued?

Compared to the current market price of 54 EUR, Laboratorios Farmaceuticos ROVI SA is Undervalued by 21%.

Back to Top